Abstract
Purpose
Routinely collected data (RCD) from electronic health records (EHR) are useful for studying disease epidemiology in the real world. We examined cough presentation and cough-related healthcare utilization using an academic institutional EHR database in Korea.
Methods
In this retrospective cohort study, patients with subacute (3–8 weeks) or chronic cough (> 8 weeks in duration) referred to allergy and asthma clinics were studied. Cases were identified using the search term “cough” or “coughing,” which is the chief complaint, in the data fields. Structured data, including demographics, medical history, symptoms, and diagnostic tests, were analyzed. Healthcare utilization was assessed for drug prescriptions, additional tests, or outpatient visits for 1 year.
Results
Cough was the chief complaint in 13,223 cases (46.7%) among 28,312 new referrals for 8 years. A total of 3810 subacute and 7150 chronic cough patients were analyzed. The common demographic profile was middle-aged woman (mean age 52.1 years), reported in 63% of the cases. Cough was frequently accompanied by anterior nasal (about 50%), lower airway (30%), or acid reflux disease symptoms (20%), and by test abnormalities in chest X-rays (14%), spirometry (23%), or T2 inflammation markers (40%). Chronic cough patients frequently required additional tests (chest CT scan: 24%), drug prescriptions (codeine: 21.5% and oral steroids: 9.9%), and long-term healthcare utilization (16.0%) for 1 year.
Conclusions
Cough is a common chief complaint at allergy and asthma clinics, but the clinical presentation may be heterogeneous. Further studies are needed to understand long-term outcomes and reduce the disease burden.
Similar content being viewed by others
Abbreviations
- COPD:
-
Chronic obstructive pulmonary disease
- RCD:
-
Routinely collected data
- EHR:
-
Electronic health record
- ICD:
-
International Statistical Classification of Diseases
- CRF:
-
Case report form
- PND:
-
Postnasal drip
- ILD:
-
Interstitial lung disease
- GERD:
-
Gastro-esophageal reflux disease
- DM:
-
Diabetes mellitus
- ACEi:
-
Angiotensin-converting enzyme inhibitor
- FeNO:
-
Fractional exhaled nitric oxide
- FEV1:
-
Forced expiratory volume in 1 s
- FVC:
-
Forced vital capacity
- CT:
-
Computed tomography
- ICS:
-
Inhaled corticosteroid
- PPI:
-
Proton pump inhibitor
- OCS:
-
Oral corticosteroids
- IQR:
-
Interquartile range
References
Dicpinigaitis PV (2015) Clinical perspective—cough: an unmet need. Curr Opin Pharmacol 22:24–28
Song WJ, Chang YS, Faruqi S, Kim JY, Kang MG, Kim S, Jo EJ, Kim MH, Plevkova J, Park HW, Cho SH, Morice AH (2015) The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 45(5):1479–1481
French CL, Irwin RS, Curley FJ, Krikorian CJ (1998) Impact of chronic cough on quality of life. Arch Intern Med 158(15):1657–1661
Won HK, Lee JH, An J, Sohn KH, Kang MG, Kang SY, Morice AH, Cho SH, Song WJ (2020) Impact of chronic cough on health-related quality of life in the Korean adult general population: the Korean national health and nutrition examination survey 2010–2016. Allergy Asthma Immunol Res 12(6):964–979
Rudrapatna VA, Butte AJ (2020) Opportunities and challenges in using real-world data for health care. J Clin Investig 130(2):565–574
McGarvey L, Gibson PG (2019) What is chronic cough? Terminology. J Allergy Clin Immunol 7(6):1711–1714
Irwin RS, French CL, Chang AB, Altman KW, Adams TM, Azoulay E, Barker AF, Birring SS, Blackhall F, Bolser DC (2018) Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest 153(1):196–209
Song DJ, Song WJ, Kwon JW et al (2018) KAAACI evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res 10(6):591–613
Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365
Dalal AA, Duh MS, Gozalo L, Robitaille M-N, Albers F, Yancey S, Ortega H, Forshag M, Lin X, Lefebvre P (2016) Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma. J Manag Care Spec Pharm 22(7):833–847
Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55:1
Cherry DK, Woodwell DA, Rechtsteiner EA (2007) National ambulatory medical care survey: 2005 summary. Adv Data (387):1–39
Cho S-H, Lin H-C, Ghoshal AG, Bin Abdul Muttalif AR, Thanaviratananich S, Bagga S, Faruqi R, Sajjan S, Brnabic AJ, Dehle FC (2016) Respiratory disease in the Asia-Pacific region: Cough as a key symptom. In: Allergy & Asthma Proc. https://doi.org/10.2500/aap.2016.37.3925
Zeiger RS, Xie F, Schatz M, Hong BD, Weaver JP, Bali V, Schelfhout J, Chen W (2020) Prevalence and characteristics of chronic cough in adults identified by administrative data. Perm J 24:1–3
Zeiger RS, Schatz M, Butler RK, Weaver JP, Bali V, Chen W (2020) Burden of specialist-diagnosed chronic cough in adults. J Allergy Clin Immunol Pract 8(5):1645–1657
Zeiger RS, Schatz M, Hong B, Li Q, Stern JA, Takhar HS, Weaver JP, Bali V, Schelfhout J, Chen W (2021) Patient-reported burden of chronic cough in a managed care organization. J Allergy Clin Immunol Pract 9(4):1624–1637
Kim AM, Cho S, Kim HJ, Jung H, Jo MW, Lee JY, Eun SJ (2018) Primary care patients’ preference for hospitals over clinics in Korea. Int J Environ Res Public Health 15:6. https://doi.org/10.3390/ijerph15061119
Won HK, Kang SY, Kang Y et al (2019) Cough-related laryngeal sensations and triggers in adults with chronic cough: symptom profile and impact. Allergy Asthma Immunol Res 11(5):622–631
Kang SY, Song WJ, Won HK, Chung SJ, Kim JY, Park HW, Morice AH, Cho SH (2020) Cough persistence in adults with chronic cough: A 4-year retrospective cohort study. Allergol Int 69(4):588–593
Morice AH, Birring SS, Smith JA, McGarvey LP, Schelfhout J, Martin Nguyen A, Xu ZJ, Wu WC, Muccino DR, Sher MR (2021) Characterization of patients with refractory or unexplained chronic cough participating in a phase 2 clinical trial of the P2X3-receptor antagonist gefapixant. Lung 199(2):121–129
Acknowledgements
None.
Funding
This study was supported in part by a research grant from Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp.
Author information
Authors and Affiliations
Contributions
Each of the authors confirms that this manuscript has not been previously published and is not currently under consideration by any other journal. Additionally, all authors have approved the contents of this paper and have agreed to the journal submission policies. WJS contributed to the design of the study. JA performed the main analysis and wrote the original draft. JHL, HKW, and YK assisted in the analysis and interpretation of the data. HSK, JSL, SWL, TBK, YMO, YSC, SDL, and HBM collected the data. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interest
The authors declare that they have no competing interest.
Ethical Approval
This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by the hospital institutional review board (IRB No. 2019–0511).
Consent to Participate
Individual subject informed consent was waived due to the retrospective nature of the study and no prospective engagement with subjects or their legal guardians.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
An, J., Lee, JH., Won, HK. et al. Cough Presentation and Cough-Related Healthcare Utilization in Tertiary Care: Analysis of Routinely Collected Academic Institutional Database. Lung 200, 431–439 (2022). https://doi.org/10.1007/s00408-022-00555-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-022-00555-w